Login / Signup

Rapid and sustained response to JAK inhibition in a child with severe MDA5 + juvenile dermatomyositis.

Timmy StraußClaudia GüntherAnja SchnabelChristine WolfGabriele HahnMin Ae Lee-KirschNormi Brück
Published in: Pediatric rheumatology online journal (2023)
While there is growing evidence that JAK inhibition is a promising therapeutic option in jDM our case report shows that this approach may also be effective in MDA5-positive jDM with high risk features.
Keyphrases
  • case report
  • breast cancer cells
  • mental health
  • rheumatoid arthritis
  • cell proliferation
  • systemic lupus erythematosus
  • drug induced